Publication | Closed Access

Evaluation of the protection conferred by commercial vaccines and attenuated heterologous isolates in China against the CK/CH/LDL/97I strain of infectious bronchitis coronavirus

VaccinationInfectious Bronchitis CoronavirusVaccine DevelopmentVaccine TargetImmunologyCommercial VaccinesVirologyCk/ch/ldl/97i StrainInfection ControlPolyvalent VaccineMedicineVaccine ResearchEpidemiologyCovid-19